Targeting CD36-mediated inflammation reduces acute brain injury in transient, but not permanent, ischemic stroke.

This is a source-metadata record last found in a complete check on Sep 25, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.

Source status: This saved record has not yet had a scheduled exact-ID status check. Check its original source links.

Study metadata

Study type: Original study
Study category (metadata hint): Animal
Published: 2014-09-12
Authors: Kim EH, Tolhurst AT, Szeto HH, Cho SH.
Journal or registry: CNS neuroscience & therapeutics
Registry study design: Not reported
Registry enrollment: Not reported
Funding agencies: National Institutes of Health; NINDS NIH HHS; NHLBI NIH HHS; Burke Foundation
Identifiers: DOI: 10.1111/cns.12326 · PMID: 25216018 · PMCID: PMC4362808
First found: Sep 25, 2026
Last found: Sep 25, 2026

Original sources

View at Europe PMC ↗View at PubMed ↗